ADMA Biologics, Inc. (ADMA) Max Pain Analysis
Max pain is the strike price where aggregate option buyer payout is minimized at expiration. It represents the price at which option writers retain the most premium.
ADMA Biologics, Inc. (ADMA) operates in the Healthcare sector, specifically the Biotechnology industry, with a market capitalization near $1.97B, listed on NASDAQ, employing roughly 685 people, carrying a beta of 0.82 to the broader market. ADMA Biologics, Inc. Led by Adam S. Grossman, public since 2013-10-17.
Snapshot as of May 15, 2026.
- Spot Price
- $8.27
- Total OI
- 132.3K